Jan 21, 2026
cancer treatments
is marked by a rapid shift from one‑size‑fits‑all chemotherapy to — including blood‑based minimal residual disease (MRD) testing to tailor adjuvant therapy, expanded cell and radioligand therapies, ne...
Ivermectin and immunotherapies
There is interest in combining ivermectin with immunotherapies, but no completed trials have demonstrated its clinical benefit